Salvage Radical Prostatectomy

Abstract

The aim of this film is to demonstrate that salvage radical prostatectomy can be performed preserving urinary continence and with a morbility rate comparable to that of radical prostatectomy performed de novo in patients with a previously untreated tumor. Three consecutive rises in PSA level, above the nadir PSA, and the presence of biopsy-proven prostate cancer, show a recurrent or persistent disease in a patient with prostate cancer, treated with full-dose radiation therapy. Thus, when patients present a life expectancy of at least 10 years and organ-confined disease, salvage radical prostatectomy is the only option of therapy most likely to achieve lasting local control.